1. 220 Specific protein degradation products of collagen and vimentin as well as fibronectin are released from the tumor core and adjacent tissue in a human colorectal tumor ex vivo model - biomarker potential. (September 2015) Authors: Willumsen, N.; Bager, C.L.; Bay-Jensen, A.C.; Quilez Alvarez, A.; Harling, H.; Leeming, D.J.; Karsdal, M.A.; Jorgensen, L. Nannestad Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 274 Development of a novel marker for detection of degradation and formation of fibronectin in cancer ex vivo models. (September 2015) Authors: Bager, C.L.; Bay-Jensen, A.C.; Leeming, D.J.; Gudmann, N.S.; Karsdal, M.; Balslev, I.; Christiansen, A.P.; Høgdall, E.; He, Y. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 275 ECM degradation products are released from kidney tumor tissue and adjacent tissue. (September 2015) Authors: Bager, C.L.; Willumsen, N.; Quilez-Alvarez, A.; Bay-Jensen, A.C.; Leeming, D.J.; Karsdal, M.; Christiansen, A.P.; Balslev, I.; Høgdall, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 427 A serum biomarker reflecting basement membrane degradation predicts mortality in breast cancer patients one year prior to detection of metastatic disease. (September 2015) Authors: Willumsen, N.; Bager, C.L.; Leeming, D.J.; Karsdal, M.A.; Bay-Jensen, A.C.; Brandslund, I. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 436 The Prospective Epidemiologic Risk Factor (PERF I) Study: A novel prognostic serum biomarker reflecting type I collagen degradation is associated with tumor burden. (September 2015) Authors: Kehlet, S.N.; Bager, C.L.; Willumsen, N.; Dragsb, K.; Neergaard, J.S.; Hansen, H.B.; Bay-Jensen, A.C.; Oersnes-Leeming, D.J.; Christiansen, C.; Karsdal, M.A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗